LOGIN  |  REGISTER
Recursion

CyncHealth Selects Health Catalyst to Elevate Health Data Management

November 06, 2024 | Last Trade: US$8.25 0.49 6.31

SALT LAKE CITY, Nov. 6, 2024 /PRNewswire/ -- Health Catalyst, Inc. ("Health Catalyst," Nasdaq: HCAT), a leading provider of data and analytics technology and services to healthcare organizations, today announced a new partnership with CyncHealth, the designated statewide health information exchange (HIE) for Iowa.

This partnership will enhance CyncHealth's ability to provide comprehensive and timely patient health information to healthcare providers. CyncHealth will improve the quality of care within its network by working with Health Catalyst to leverage their data and analytics—as well as the interoperability of Ninja Universe by Health Catalyst™, an end-to-end cloud-native platform which is part of Health Catalyst's next-generation Ignite™ data and analytics ecosystem, and a set of applications purpose-built for HIEs.

Health Catalyst will tap into Ninja Universe to efficiently parse data to support more accurate, timely, and secure transfer of essential Continuity of Care Documents (CCDs), which summarize patient health information across different healthcare entities within the CyncHealth network.

 "CyncHealth looks forward to collaborating with Health Catalyst as we work to transform healthcare and advance interoperability in Iowa. Leveraging our analytics to arm our providers with critical CCDs is another strong step toward that goal," says Dr. Jaime Bland, CEO of CyncHealth.

CCDs provide a consistent format for health data exchange, ensuring that healthcare providers across different systems can access and understand critical patient information. Secure data exchange is vital for coordinated care, especially in cases where a patient sees multiple specialists or transitions between care settings.

"We're excited for this opportunity to partner with CyncHealth in their crucial role serving as a reliable healthcare data collector," said Dan Burton, CEO of Health Catalyst. "Access to secure data across a care network is essential to enhancing both the patient and provider experience. We look forward to the meaningful improvement CyncHealth will enable across the state through this trailblazing work."

About Health Catalyst

Health Catalyst is a leading provider of data and analytics technology and services to healthcare organizations committed to being the catalyst for massive, measurable, data-informed healthcare improvement. Its clients leverage the cloud-based data platform—powered by data from more than 100 million patient records and encompassing trillions of facts—as well as its analytics software and professional services expertise to make data-informed decisions and realize measurable clinical, financial, and operational improvements. Health Catalyst envisions a future in which all healthcare decisions are data informed.

CyncHealth

CyncHealth connects over 5 million lives and over 1,100 facilities across Nebraska and Iowa. This network includes hospitals, clinics, long-term care facilities, and other healthcare providers. By sharing data like patient histories, lab results, and immunizations, CyncHealth helps doctors and nurses provide better care.

Media Contact:

Amanda Flanders 
Senior Vice President of Marketing and Communications
This email address is being protected from spambots. You need JavaScript enabled to view it.
808.743.1781

Terns Pharmaceuticals

Stock Quote

Featured Stock

Recursion

Recursion Pharmaceuticals is a clinical stage TechBio company leading the space by decoding biology to industrialize drug discovery. Enabling its mission is the Recursion OS, a platform built across diverse technologies that continuously expands one of the world’s largest....

CLICK TO LEARN MORE

Featured Stock

C4 Therapeutics

C4 Therapeutics is pioneering a new class of small-molecule drugs that selectively destroy disease-causing proteins via degradation using the innate machinery of the cell. This targeted protein degradation approach offers advantages over traditional drugs, including the potential to treat a wider range of diseases...

CLICK TO LEARN MORE

End of content

No more pages to load

Next page

COPYRIGHT ©2023 HEALTH STOCKS HUB